Ruxolitinib for pediatric patients with treatment-naïve and steroid-refractory acute graft-versus-host disease: the REACH4 studyFranco Locatelli, Cristina Díaz de Heredia, Fanny Rialland et al.|Blood|2024Cited by 24
Ruxolitinib in Pediatric Patients with Treatment-<i>Naïve</i> or Steroid-Refractory Acute Graft-Versus-Host Disease: Primary Findings from the Phase I/II REACH4 StudyFranco Locatelli, Cristina Díaz de Heredia, Hyoung Jin Kang et al.|Blood|2022Cited by 11